Harmony Biosciences Holdings, Inc. Common Stock

€25.85
EUR
Last updated on --.
24h volume15.00
24h highest26.0780 EUR
24h lowest26.0780 EUR
24h Price movement+0.02%

HRMY recent prices

24 Hours
+0.02%+€0.0042955
30 days
-3.08%-€0.82044
60 days
+13.62%+€3.105
90 days
+3.60%+€0.89776

Key data

Previous close25.8503 EUR
Market cap1.56B EUR
Volume15.00
P/E ratio12.480000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)2.1649 EUR
Net income (FY)125.10M EUR
Revenue (FY)772.42M EUR
Last report dateMay 7, 2026

About Harmony Biosciences Holdings, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersPLYMOUTH MEETING
Employees (FY)293.00
Revenue per employee (FY)2.64M EUR
Net income per employee (FY)426.96K EUR
Listed onNasdaq
Official website

HRMY conversion tables

HRMYHRMY
EUREUR
0.5 HRMY12.92 EUR
1 HRMY25.85 EUR
5 HRMY129.27 EUR
10 HRMY258.54 EUR
EUREUR
HRMYHRMY
0.5 EUR0.019339 HRMY
1 EUR0.038678 HRMY
5 EUR0.19339 HRMY
10 EUR0.38678 HRMY

FAQ

HRMY is trading at €25.85, +0.02% over the last 24 hours. Track live moves on the price chart at the top of this page.
The HRMY stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HRMY is currently trading at €25.85, +0.02% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HRMY price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HRMY's P/E ratio is currently 12.480000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HRMY; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HRMY's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Harmony Biosciences Holdings, Inc. Common Stock's market cap is currently 1.56B EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume15.00
24h highest26.0780 EUR
24h lowest26.0780 EUR
24h Price movement+0.02%
HRMYHRMY
EUREUR
Start trade with HRMY Perpetual